Tissue Regenix Group PLC | Ownership
Companies that own Tissue Regenix Group PLC
Invesco Asset Management Ltd.
336,709,939
28.74%
125,381,588
0.05%
09/04/2017
Woodford Investment Management Ltd.
304,698,872
26%
13,491,000
0.24%
04/18/2018
Jupiter Asset Management Ltd.
68,885,745
5.88%
35,577,353
0.02%
08/09/2017
Baillie Gifford & Co.
50,550,887
4.3%
-3,957,780
0%
12/31/2016
NFU Mutual Investment Services Ltd.
26,264,000
2.24%
-300,000
0.05%
08/10/2017
United Nations Joint Staff Pension Fund
26,220,000
2.24%
0
0.17%
07/02/2018
Henderson Global Investors Ltd.
16,696,000
1.43%
0
0%
07/02/2018
HSBC Global Asset Management (UK) Ltd.
8,833,000
0.75%
-1,038,000
0%
07/02/2018
Hargreaves Lansdown Stockbrokers Ltd.
8,720,000
0.74%
-1,205,000
0.01%
07/02/2018
Hargreaves Lansdown Asset Management Ltd.
3,838,000
0.33%
-139,000
0.01%
07/02/2018
| Address |
Astley Lane Industrial Estate
Leeds Yorkshire LS26 8XT
United Kingdom
|
|
Employees
|
- |
| Website |
http://tissueregenix.com |
| Updated |
07/08/2019 |
| Tissue Regenix Group Plc is a medical technology company, which develops and commercializes platform technologies in the field of tissue engineering and regenerative medicine. Its patented decellularisation technology removes DNA and other cellular material from animal and human tissue leaving a cellular tissue scaffold, which is not rejected by the patient's body which can then be used to repair diseased and worn out body parts. The potential applications of this process address clinical needs such as vascular disease, heart valve replacement and knee repair. |
